Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis

Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis

Patient populations, including those with hematological malignancies, have different responses to COVID-19 vaccines. This study aimed to quantitatively analyze the efficacy and safety of COVID-19 mRNA vaccines in patients with hematological malignancies. Studies reporting on the efficacy and safety...

Full description

Bibliographic Details
Main Authors: Ikhwan Rinaldi, Samuel Pratama, Lowilius Wiyono, Jeremy Rafael Tandaju, Indy Larasati Wardhana, Kevin Winston
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
COVID-19
mRNA vaccine
hematologic malignancies
seroconversion rates
antibody titers
adverse effects
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.951215/full

Similar Items

Similar Items